ATSDR
Environmental Medicine | CSEM | GREM | Continuing Education | Patient Education | PEHT | Community
Section Contents
Learning Objectives
Introduction
Inhalation
Ingestion
Skin
Key Points
Progress Check
 
Case Contents
Table of Contents
Cover Page
How to Use This Course
Initial Check
Chromium
Where Found
Who Is at Risk
Standards, Regulations
Biological Fate
Physiologic Effects
Signs & Symptoms
Laboratory Tests
Treatment
Patient Education
More Information
Posttest
Literature Cited
Printer-Friendly Printer-Friendly
 
Environmental Medicine
CSEM
GREM
PEHT
Continuing Education
Online Registration
Patient Education
Community Education
 
ATSDR Resources
ATSDR en Español
Case Studies (CSEM)
Exposure Pathways
HazDat Database
Health Assessments
Health Statements
Interaction Profiles
Interactive Learning
Managing Incidents
Medical Guidelines
Minimal Risk Levels
Priority List
ToxFAQs™
ToxFAQs™ CABS
Toxicological Profiles
Toxicology Curriculum
 
External Resources
CDC
eLCOSH
EPA
Healthfinder®
Medline Plus
NCEH
NIEHS
NIOSH
OSHA

Agency for Toxic Substances and Disease Registry 
Case Studies in Environmental Medicine (CSEM) 
Chromium Toxicity
What Are the Routes of Exposure for Chromium?

Learning Objectives

Upon completion of this section, you will be able to

  • identify the routes of exposure to chromium.

Introduction

The entry routes of chromium into the human body are inhalation, ingestion, and dermal absorption. Occupational exposure generally occurs through inhalation and dermal contact, whereas the general population is exposed most often by ingestion through chromium content in soil, food, and water.

Inhalation

After human exposure to Cr(III) by inhalation, urinary concentrations of chromium were found to be increased indicating respiratory absorption [Aitio, Jarvisalo et al. 1984; Foa, Riboldi et al. 1988; Dayan and Paine 2001].

Data from a few animal experiments indicate that with equal solubility, Cr(VI) compounds are absorbed more readily than Cr(III) compounds, probably because Cr(VI) readily penetrates cell membranes [Mertz 1969; Wiegand, Ottenwalder et al. 1984].

Cr(VI) is reduced to Cr(III) in the lower respiratory tract by the epithelial lining fluid and by pulmonary alveolar macrophages [Dayan and Paine 2001]. One study showed that at equivalent numbers of cells, the reducing efficiency of alveolar macrophages by biochemical mechanisms was significantly greater in tobacco smokers than in nonsmokers [Petrilli, Rossi et al. 1986].

Ingestion

In general, Cr(VI) compounds are better absorbed through the intestinal mucosa than the Cr(III) compounds. However, due to the actions of stomach acid and other components within the gastrointestinal tract, most of an ingested Cr(VI) dosage is converted to Cr(III) [Cohen, Kargacin et al. 1993]. In humans and animals, less than 1% of inorganic Cr(III) and about 10% of inorganic Cr(VI) are absorbed from the gut; the latter amount is slightly higher in a fasting state [Donaldson and Barreras 1966; Dayan and Paine 2001].

Skin

Data from volunteers and indirect evidence from occupational studies indicate that absorption of Cr(VI) compounds can occur through intact skin [Baranowska-Dutkiewicz 1981]. Studies in experimental animals showed poor absorption of Cr(III) compounds following dermal route [Dayan and Paine 2001].

Key Points

  • Occupational exposure generally occurs through inhalation and dermal contact, whereas the general population is exposed most often by ingestion through chromium content in soil, food, and water.
  • The majority of Cr(VI) that enters the body via inhalation or ingestion is quickly reduced to Cr(III).

Progress Check



Choose the best answer.

3.

Which of following statements regarding exposure pathway is correct?

A. Cr(VI) and Cr(III) have equal capacity to be absorbed through any routes into the human body.
B. Cigarette smoking has no impact on absorption of chromium.
C. The general population is exposed most often by ingestion through chromium content in soil, food, and water.
D. None of the above.

Answer:

To review relevant content, see Introduction in this section.

Previous Section

Next Section

Revised 2008-12-08.